Newly-formed BioCity Scotland, a centralized base for growing bioscience, pharameutical, med tech and health companies, will set up house in the former-MSD research facility at Newhouse, which it acquired Jan. 11.

A joint venture between BioCity Nottingham and Roslin BioCentre, BioCity Scotland will be 15 miles from Glasgow and 33 miles from Edinburgh, a central location for growing companies in Scotland.

The 130,000-square-foot facility consists of purpose-built labs and offices on 23 acres and is capable of supporting pre-clinical drug discovery and development by a range of independent companies. It is equipped with administrative and conference facilities to provide support and networking capabilities for client companies.

BioCity Scotland will provide access to a range of state-of-the-art equipment, available to rent at competitive rates. On-site business support will allow companies to tap into funding opportunities to assist their growing business needs.

“BioCity Scotland is much more than a property proposition—it will be a unique, vibrant community of scientific companies,” said Louis J. Nisbet, chairman of BioCity Scotland. “BioCity Nottingham's success in nurturing and growing over 70 new companies since 2003, and Roslin's expertise in life sciences innovation and facilities management makes this team the perfect commercial partnership."